News
Pramipexole dihydrochloride extended-release 0.375mg, 0.75mg, 1.5mg, 2.25mg, 3mg, 3.75mg ... not take both immediate-release pramipexole and Mirapex ER. Dopamine agonists may impair the systemic ...
Pramipexole oral tablets are available as the brand-name drugs Mirapex and Mirapex ER. Pramipexole is also available as a generic drug. Generic drugs usually cost less than the brand-name version.
Silver Spring, MD - The US Food and Drug Administration has notified healthcare professionals about a possible risk for heart failure with pramipexole (Mirapex, Boehringer Ingelheim), a dopamine ...
"I thought, 'Oh my God, this must be it,'" he said. Three days after stopping the drug, Mirapex, "all desire to gamble just went away completely. I felt like I had my brain back." A Mayo Clinic ...
[9-19-2012] The U.S. Food and Drug Administration (FDA) is informing the public about a possible increased risk of heart failure with Mirapex (pramipexole), a drug used to treat Parkinson's ...
My doctor said it was the cause of some sensitivity and agitation I had in my upper body (especially the back) and prescribed Mirapex. But I often forget to take it, and my symptoms haven't returned.
“I thought, 'Oh my God, this must be it,”’ he said. Three days after stopping the drug, Mirapex, “all desire to gamble just went away completely. I felt like I had my brain back.
The dopamine agonist drugs -- pramipexole (Mirapex) and ropinirole (Requip) -- are also approved for treatment of restless legs syndrome. In the study, researchers looked at the medical records of ...
The study of more than 3,000 people with Parkinson's disease confirms that so-called dopamine agonists, such as GlaxoSmithKline's <GSK.L> Requip or ropinirole or Boehringer Ingelheim's Mirapex or ...
Pramipexole dihydrochloride extended-release 0.375mg, 0.75mg, 1.5mg, 2.25mg, 3mg, 3.75mg ... not take both immediate-release pramipexole and Mirapex ER. Dopamine agonists may impair the systemic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results